CGM to Aid Transition From Inpatient to Outpatient
Continuous Glucose Monitoring in the Hospital to Aid in Care and Improve Transition of Care to Outpatient
Sponsor: Methodist Medical Center of Illinois
Listed as NCT03155594, this NA trial focuses on Diabete Mellitus and remains ongoing. Sponsored by Methodist Medical Center of Illinois, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status NA
-
Jun 2019 — Feb 2020 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Methodist Medical Center of Illinois
For direct contact, visit the study record on ClinicalTrials.gov .